Directed evolution of conformation‐specific antibodies for sensitive detection of polypeptide aggregates in therapeutic drug formulations-Reference-Cited by-同舟云学术

Directed evolution of conformation‐specific antibodies for sensitive detection of polypeptide aggregates in therapeutic drug formulations

Published:2020-11-22 Issue:2 Volume:118 Page:797-808
ISSN:0006-3592
Container-title:Biotechnology and Bioengineering
language:en
Short-container-title:Biotechnology and Bioengineering

Author:

Lou Wenjia¹²,Stimple Samuel D.¹²,Desai Alec A.²,Makowski Emily K.¹,Kalyoncu Sibel³,Mogensen Jesper E.⁴,Spang Lotte T.⁴,Asgreen Désirée J.⁴,Staby Arne⁴,Duus Karen⁴,Amstrup Jan⁴,Zhang Yulei²,Tessier Peter M.¹²³⁵^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, Biointerfaces Institute University of Michigan Ann Arbor Michigan USA

2. Department of Chemical Engineering, Biointerfaces Institute University of Michigan Ann Arbor Michigan USA

3. Isermann Department of Chemical and Biological Engineering, Center for Biotechnology and Interdisciplinary Studies Rensselaer Polytechnic Institute Troy New York USA

4. Novo Nordisk A/S Bagsværd Denmark

5. Department of Biomedical Engineering, Biointerfaces Institute University of Michigan Ann Arbor Michigan USA

Funder

Novo Nordisk

Publisher

Wiley

Subject

Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bit.27610

Reference48 articles.

1. Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice